Page last updated: 2024-09-05

muraglitazar and ns-220

muraglitazar has been researched along with ns-220 in 1 studies

Compound Research Comparison

Studies (muraglitazar)	Trials (muraglitazar)	Recent Studies (post-2010) (muraglitazar)	Studies (ns-220)	Trials (ns-220)	Recent Studies (post-2010) (ns-220)
85	10	25	5	0	1

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goel, A; Jain, M; Jamili, J; Makadia, P; Patel, M; Patel, P; Patil, P; Pingali, H; Sairam, KV; Shah, S; Zaware, P	1

Other Studies

1 other study(ies) available for muraglitazar and ns-220

Article	Year
Modulation of PPAR receptor subtype selectivity of the ligands: aliphatic chain vs aromatic ring as a spacer between pharmacophore and the lipophilic moiety. Bioorganic & medicinal chemistry letters, 2008, Dec-15, Volume: 18, Issue:24 Topics: Butyrates; Chemistry, Pharmaceutical; Dioxanes; Drug Design; Glycine; Humans; Hydrogen; Hydrogen Bonding; Ligands; Models, Chemical; Oxazoles; Peroxisome Proliferator-Activated Receptors; PPAR alpha; Transcriptional Activation	2008

Article

Year

Modulation of PPAR receptor subtype selectivity of the ligands: aliphatic chain vs aromatic ring as a spacer between pharmacophore and the lipophilic moiety.

Bioorganic & medicinal chemistry letters, 2008, Dec-15, Volume: 18, Issue:24

Topics: Butyrates; Chemistry, Pharmaceutical; Dioxanes; Drug Design; Glycine; Humans; Hydrogen; Hydrogen Bonding; Ligands; Models, Chemical; Oxazoles; Peroxisome Proliferator-Activated Receptors; PPAR alpha; Transcriptional Activation

2008